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Abstract
Inflammation may be caused by a variety of factors and is a hallmark of a plethora of acute and 
chronic diseases. The purpose of inflammation is to eliminate the initial cell injury trigger, to clear 
out dead cells from damaged tissue and to initiate tissue regeneration. Despite the wealth of 
knowledge regarding the involvement of cellular communication in inflammation, studies on the 
role of connexin-based channels in this process have only begun to emerge in the last few years. In 
this paper, a state-of-the-art overview of the effects of inflammation on connexin signaling is 
provided. Vice versa, the involvement of connexins and their channels in inflammation will be 
discussed by relying on studies that use a variety of experimental tools, such as genetically 
modified animals, small interfering RNA and connexin-based channel blockers. A better 
understanding of the importance of connexin signaling in inflammation may open up towards 
clinical perspectives.
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1 Introduction
In multicellular organisms, homeostasis is controlled by 3 communication mechanisms 
acting at the intracellular, extracellular and intercellular level. The latter is mainly mediated 
by gap junctions (GJs) (Su and Lau, 2014), which appear as plaques at the cell plasma 
membrane surface and are formed by the interaction of 2 hemichannels (HCs), one 
contributed by each of the adjacent cells (Vinken et al., 2006, Vinken et al., 2011). Each HC 
is composed of 6 connexins (Cxs), which are transmembrane (TM) proteins consisting of a 
cytoplasmic loop (CL), 2 extracellular loops (EL), a cytoplasmic C-terminal tail and a 
cytoplasmic N-terminal tail (Vinken et al., 2012, Maes et al., 2014). More than 20 different 
Cx species have been identified in human and they are all named after their predicted 
molecular weight, expressed in kilodaltons. GJs allow the intercellular transfer of small and 
hydrophilic molecules with a molecular weight below 1-1.5 kilodalton, such as adenosine 
triphosphate (ATP), inositol triphosphate and cyclic adenosine monophosphate, as well as 
ions. This flux is called gap junctional intercellular communication (GJIC) (Decrock et al., 
2009, Chandrasekhar and Bera, 2012, Wang et al., 2013b). The latter can be regulated by 
different mechanisms including pH, transmembrane voltage and calcium concentration 
(Cottrell and Burt, 2005). Posttranslational modifications, such as S-nitrosylation, 
sumoylation and phosphorylation, also directly regulate gap junction opening (Johnstone et 
al., 2012). Upon degradation, gap junctional channels are internalized by one of the 2 
opposing cells, resulting in the formation of an annular gap junction. These structures are 
further degraded by both lysosomes and proteasomes (Laird, 2005, Laird, 2006). When 
unopposed, HCs have the potential to form a transmembrane conduit between the cytosol of 
an individual cell and its extracellular environment, and to convey a number of critical 
molecules, including ATP, nicotinamide adenine dinucleotide, glutamate and prostaglandins 
(Figure 1) (Wang et al., 2013b). While GJs are usually open in physiological conditions, 
HCs are typically closed yet can be activated by a number of pathological triggers, such as 
increases membrane depolarization, increases in intracellular calcium (De Vuyst et al., 2006, 
Wang et al., 2013a) or decrease in extracellular calcium concentration (Srinivas et al., 2006), 
mechanical stimulation (Luckprom et al., 2011), changes in Cx phosphorylation status 
(Alstrom et al., 2015), oxidative stress (Riquelme and Jiang, 2013), ischemia/reperfusion 
insults (Wang et al., 2013c) and inflammatory conditions (Takeuchi and Suzumura, 2014, 
Calder et al., 2015). Cx proteins can also affect cellular functions independently of their 
channel-forming properties by altering the expression of homeostasis determinants or by 
direct interaction with cell growth and cell death regulators through binding of cytoplasmic 
proteins to the C-terminal tail (Vinken et al., 2012, De Bock et al., 2015).
Interesting experimental and therapeutic tools are the peptide inhibitors of connexin-based 
channels, especially those who mimic specific connexin sequences. In contrast to 
carbenoxolone, a typical inhibitor of GJs and connexin-based HC’s, these mimetic peptides 
have better selectivity. Over the past ten years, several peptides have been demonstrated to 
block hemichannels, including Gap26, a peptide identical to a sequence on the first EL of 
Cx43 (Wang et al., 2013a), Gap27, a peptide identical to a sequence on the second EL of 
Cx37 and Cx43 (De Bock et al., 2011), Peptide5, a Cx43 HC-blocking mimetic peptide 
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(Danesh-Meyer et al., 2012) and Gap19, a synthetic nonapeptide that mimics a sequence in 
the cytoplasmic loop area of Cx43 (Wang et al., 2013a).
Inflammation is a first-line mechanism in the innate immune response in order to protect the 
organism against pathogens and deleterious effects of cell damage. This complex process 
encompasses a multistep reaction, involving recruitment of immune cells, vasodilatation, 
increased permeability and an extensive set of molecular mediators. Its goal is to eliminate 
the initial cause of cell injury, clear out necrotic cells damaged upon the insult and to initiate 
tissue repair (Toskala, 2014, Shalapour and Karin, 2015, Waisman et al., 2015). Both 
microbiologically-induced inflammation and sterile inflammation are characterized by the 
recruitment of neutrophils and macrophages as well as by the production of inflammatory 
cytokines and chemokines (Chen and Nuñez, 2010). In particular, Toll-like receptors are 
expressed on various immune cells, such as macrophages, dendritic cells, B-cells and 
neutrophils, and on non-immune cells in brain, heart, intestine, lung, liver and kidney 
(Kawai and Akira, 2007, Vaure and Liu, 2014). Toll-like receptors constitute a family of 
primary sensors that detect damage-associated molecular patterns (DAMPs) (Chen and 
Nuñez, 2010), released by damaged cells, or pathogen-associated molecular patterns 
(PAMPs), like peptidoglycan from most bacteria and lipopolysaccharide (LPS) from Gram-
negative bacteria (Akira et al., 2006, Kawai and Akira, 2007, Lu et al., 2008). Toll-like 
receptor activation occurs through receptor dimerization, which requires cluster of 
differentiation 14 and myeloid differentiation factor 2. Subsequently, the transcription factor 
nuclear factor (NF) κ-light-chain-enhancer of activated B cells κB, present in the cytosol 
under basal conditions, becomes activated and transported to the nucleus. At this location, 
NF-κB regulates the expression of cytokines, cyclo-oxygenase 2, growth factors and 
inhibitors of apoptosis and the expression of pro-interleukin (IL)-1β, which is then cleaved 
in the cytosol by caspase 1 to active IL-1β (Figure 2). Finally, the latter is released in the 
extracellular environment and can induce the production of an array of pro-inflammatory 
mediators, such as IL-6, tumor necrosis factor (TNF)-α and nitric oxide synthase (NOS), 
leading to NO formation (Lucas and Maes, 2013).
In the last decade, it has become clear that the inflammatory response relies, at least in part, 
on cellular communication mediated by Cx proteins and their channels (Tables 2 and 3) 
(Chanson et al., 2005, Brisset et al., 2009, Morel et al., 2009, Scheckenbach et al., 2011, 
Maes et al., 2015b, Meens et al., 2015). This paper will give an overview of these aspects in 
different organs.
2 Connexin signaling and inflammation
2.1 Brain and spinal cord
2.1.1 Effects of inflammation on connexins and their channels in the brain 
and spinal cord—The brain is a highly differentiated, heterogeneous and complex organ 
that requires various control mechanisms, including cellular communication through Cx-
based channels (Table 1) (Scheckenbach et al., 2011). In the brain, Cx43 is most 
prominently produced by astrocytes, while microglial cells mainly harbor Cx32 and Cx26 
(Giaume and Theis, 2010, Takeuchi and Suzumura, 2014). A number of other Cxs, including 
Cx26, Cx30, Cx40, Cx45 and Cx46, have been detected in astrocytes in vitro (Kunzelmann 
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et al., 1997, Dermietzel et al., 2000). Brain oligodendrocytes express Cx32, Cx47 and Cx29, 
whereas neurons produce Cx36 and Cx45 (Moore and O'Brien, 2015). The blood-brain 
barrier is a selective permeability barrier that separates circulating blood from the brain 
extracellular fluid. The blood-brain barrier is formed by endothelial cells and pericytes, 
which express Cx37, Cx40 and Cx43, as well as by astrocytes that express Cx43, Cx30 and 
Cx26 in decreasing order (Traub et al., 1998, Nagasawa et al., 2006, De Bock et al., 2014). 
In the spinal cord, developing motor neurons show expression of Cx36, Cx37, Cx40, Cx43, 
and Cx45 mRNA (Tonkin et al., 2014). Spinal astrocytes contain Cx30 and Cx43, and spinal 
oligodendrocytes stain positive for Cx29, Cx32 and Cx47.
Upon peripheral injury, pro-inflammatory cytokines are released into the blood circulation 
and attract leukocytes (Chanson et al., 2005). These cytokines make the blood-brain barrier 
more permeable, resulting in the invasion of blood cells into the central nervous system and 
hence the occurrence of neuro-inflammation (Takeuchi and Suzumura, 2014). In Rasmussen 
encephalitis, a rare condition characterized by sustained brain inflammation, epilepsy and 
progressive cognitive deterioration in children, expression of Cx32 in brain tissue is 
decreased, while Cx26 production remains unchanged. Interestingly, GJ coupling in cortical 
pyramidal neurons in brain tissue from Rasmussen encephalitis patients is enhanced (Cepeda 
et al., 2015). Demyelination, being the loss of myelin surrounding the nerves, is a hallmark 
of some neurodegenerative auto-immune diseases, including multiple sclerosis, 
encephalomyelitis and chronic inflammatory demyelinating polyneuropathy. As such, 
inflammation may drive demyelination associated with such diseases through 
overproduction of cytokines via upregulation of TNF-α (Ledeen and Chakraborty, 1998). In 
this regard, Cx32-based and Cx47-based GJ formation in oligodendrocytes is compromised 
within lesions in multiple sclerosis patients, while Cx30 and Cx43 levels are augmented as 
part of astrogliosis (Markoullis et al., 2012b, Lieury et al., 2014, Markoullis et al., 2014). 
Moreover, Cx32 production is downregulated along myelinated fibers, yet Cx47 shows 
enhanced expression mainly in oligodendrocyte precursor cells (Markoullis et al., 2012b). 
Similar changes in Cx expression patterns are observed in an experimental model of auto-
immune encephalomyelitis in mouse (Markoullis et al., 2012a). LPS injection in rats shows 
that activation of apoptosis in oligodendrocytes is an early event in demyelination 
concomitant with loss of Cx43 in the corpus callosum (Zhang et al., 2013a). Astrocytes are 
of importance in initiating and regulating the release of pro-inflammatory cytokines, 
including IL-1β and TNF-α (Dong and Benveniste, 2001, Farina et al., 2007). On their turn, 
IL-1β and TNF-α underlie the regulation of GJs and HCs in astrocytes. Overall, they reduce 
GJIC and open HCs (Orellana et al., 2009, Abudara et al., 2015). In fact, the former is 
disadvantageous for neurons as their survival heavily relies on cellular communication with 
astrocytes. Consequently, astrocytes can be considered as key players in infectious and 
neurodegenerative diseases in the central nervous system (Kielian, 2008, Quintanilla et al., 
2012). Intracerebroventricular injection of LPS in rats upregulates Cx32 mRNA levels and 
decreases Cx43 expression in the hippocampus (Abbasian et al., 2012, Sayyah et al., 2012, 
Abbasian et al., 2013). When exposed to inflammatory agents, including cytokines, LPS and 
amyloid-β, astrocytes exhibit deterioration of GJIC (De Vuyst et al., 2007, Cruz et al., 2010, 
Hinkerohe et al., 2010, Liao et al., 2010, Orellana et al., 2010, Fruscione et al., 2011), but 
increased HC activity (Retamal et al., 2007, Orellana et al., 2010, Orellana et al., 2011). In 
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this respect, IL-1β inhibits GJ coupling and GJ conductance, along with a drop in Cx43 
protein and mRNA expression in primary human fetal astrocytes (John et al., 1999, Duffy et 
al., 2000). Similarly, TNF-α treatment of primary rat astrocytes results in GJIC inhibition 
with simultaneous phosphorylation of Cx43 (Haghikia et al., 2008b). NO is a mediator of 
inflammation by influencing phagocytes, leukocyte adhesion and smooth muscle cell 
dilation. As such, exposure of astrocytes to LPS leads to a dramatic augmentation of NOS 
(Liao et al., 2010), thereby catalyzing the production of NO, and to a dose-dependent 
suppression of GJIC (Bolaños and Medina, 1996). This goes hand in hand with decreased 
Cx43 protein (Haghikia et al., 2008a, Hinkerohe et al., 2010) and mRNA expression (Liao et 
al., 2010).
Production of pro-inflammatory mediators, like TNF-α, IL-1β and NO, is initiated upon 
exposure of astrocytes and microglia to Staphylococcus aureus, a Gram-positive bacterium 
able to cause inflammation in the brain. Recognition of peptidoglycan, the major cell wall 
product of S. aureus, in astrocytes and microglia occurs through Toll-like receptor 2 (Esen et 
al., 2004). Activation of the latter influences the p38 mitogen-activated protein kinase 
pathway, which in turn reduces Cx43 mRNA and protein expression and abrogates GJIC 
(Zvalova et al., 2004, Esen et al., 2007). In contrast, upregulated Cx43 mRNA and protein 
levels are detected in primary microglia (Garg et al., 2005). Trypanosoma cruzi and 
Toxoplasma gondii, both zoonotic protozoan parasites able to invade the central nervous 
system, cause loss of GJIC in astrocytes and leptomeningeal cells without affecting Cx43 
expression or its posttranslational processing (Campos de Carvalho et al., 1998, Kielian, 
2008). Additionally, human immunodeficiency virus infection of astrocytes results in 
opening of Cx43-based HCs and triggers a slight reduction in astrocytic GJ coupling 
(Orellana et al., 2014).
HCs at the blood-brain barrier have been linked to inflammation. In endothelial cells, dye 
uptake through HCs is induced when immortalized rat brain cells are exposed to conditioned 
medium harvested from LPS-activated microglia (Orellana et al., 2009). Treatment of 
immortalized mouse endothelial cells with peptidoglycan, isolated from S. epidermidis, also 
activates Cx43-based HCs. This induces the release of ATP and results in the increased 
expression of Toll-like receptor 2, thereby potentiating the production of IL-6 (Robertson et 
al., 2010). Moreover, the inflammatory stressor bradykinin induces HC-mediated calcium 
oscillations in microvascular brain endothelial cells and subsequent blood-brain barrier 
disruption (De Bock et al., 2011). The endothelial cytoplasmic calcium concentration plays 
an important role in blood-brain barrier function, whereby an increase is associated with a 
dysfunctional barrier (De Bock et al., 2013). After ischemia, HC opening results in an 
inability for endothelial cells to osmoregulate resulting in vessel leak within 2 hours and 
microvascular disorganization. Systemic delivery of Peptide5, reduced vascular leak 
(Danesh-Meyer et al., 2012).
Following spinal cord injury in rats, accompanied by hemorrhage, damage and inflammation 
(Norenberg et al., 2004), Cx43 protein and mRNA quantities are increased in astrocytes with 
no changes in the expression of Cx32 and Cx36 (Lee et al., 2005). Fibroblast growth factor 
(FGF)-1, which is released in spinal cord injury, activates spinal astrocytes in culture leading 
to cell permeabilization, as evidenced by increased extracellular secretion of ATP and 
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cytosolic uptake of fluorescent tracers. As shown by the use of ATPase apyrase and by P2X7 
receptor antagonists, the compromised cell membrane integrity is mediated, at least in part, 
by Cx43-based HCs (Garré et al., 2010). In summary, interesting changes in Cx expression 
are observed in virtually all forms of inflammation related to the brain or spinal cord. Such 
changes may ameliorate or worsen outcomes of disease.
2.1.2 Roles of connexins and their channels in inflammation in the brain and 
spinal cord—Auto-immune encephalomyelitis experimentally evoked in Cx32-/- mice 
results in an exacerbated clinical course with more pronounced demyelination and axonal 
loss despite a similar degree of inflammation and an overall milder loss of Cx47-based and 
Cx43-based GJs (Markoullis et al., 2012a). However, the susceptibility or severity of 
experimental auto-immune encephalomyelitis does not alter in astrocyte-specific 
Cx43fl/flCx30-/- mice (Lutz et al., 2012). Treatment of astrocytes with a pro-inflammatory 
cytokine mixture consisting of TNF-α and IL-1β stimulates Cx43-based HC activity (Froger 
et al., 2010). Interestingly, application of Gap26 and Gap27 or synthetic cannabinoid 
prevents cytokine-induced neurotoxicity. This demonstrates that inflammation-induced 
astroglial HC activation fulfills a critical function in neuronal death and suggests a 
neuroprotective role of Cx43-based blockade. This is substantiated by reduction in Cx43 
expression upon treatment of spinal astrocytes with TNF-α and interferon (IFN)-γ, which 
can be prevented by blocking c-jun terminal kinase (Zhang et al., 2013b) or ubiquitin-
proteasome (Zhang et al., 2015), both involved in apoptosis, neurodegeneration and cytokine 
production. Cx43 HCs play a major role in brain inflammation (Kim et al., 2016), and 
delivery of Cx43 HC-blocking peptides (O'Carroll et al., 2008) into the ventricles of the 
brain after ischemia in near-term sheep, a model for cerebral palsy, improves functional 
elektroretinography outcomes, reduces seizure and status epilepticus, give faster return to 
normal sleep cycling and promotes both oligodendrocyte and neuronal survival (Davidson et 
al., 2012). A similar result was obtained in a preterm sheep asphyxia study (Davidson et al., 
2014). A recent study using astrocytic-specific Cx43fl/fl mice reveals a decline in ATP-
induced inflammation, less manifested macrophage and microglia recruitment, and enhanced 
functional recovery following spinal cord injury (Huang et al., 2012). Spinal cord of rats 
treated with Cx43-antisense oligonucleotides or Cx43 HC-blocking mimetic peptides show 
reduced swelling, inflammation and tissue disruption after injury (Cronin et al., 2008, 
O'Carroll et al., 2013). Cytoplasmic calcium concentration is an important factor for 
determining the functional state of the blood-brain barrier. Bradykinin can trigger 
intracellular calcium oscillations in immortalized and primary brain endothelial cells. These 
effects are inhibited by blocking Cx-based channels using carbenoxolone, small interfering 
RNA-based silencing of endothelial Cx37 and Cx43, and Gap27 (De Bock et al., 2011).
2.2 Heart
2.2.1 Effects of inflammation on connexins and their channels in heart—The 
predominant Cx species in cardiac tissue are Cx40, Cx43 and Cx45 (Table 1) (Delmar and 
Makita, 2012, Meens et al., 2015). Cx40 can be found in atrial myocytes, the atrioventricular 
node, the His-bundle and ventricular conduction system (Gros and Jongsma, 1996, Severs et 
al., 2004). Cx45 is mainly localized in the sinoatrial and atrioventricular nodes (Jansen et al., 
2010) and at the interface between the fast conducting pathway and the working 
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myocardium (Coppen et al., 1998), while Cx43 is most abundantly present in atrial and 
ventricular myocytes (Lampe and Lau, 2004, Michela et al., 2015). Most ventricular GJs 
composed of Cx43 gather at intercalated discs (Vozzi et al., 1999), often with larger 
junctional plaques at the disc periphery, and are rarely distributed to the lateral membranes 
of cardiomyocytes. The specific localization of Cx43 is essential for rapid propagation of 
action potentials (Del Ry et al., 2015, Michela et al., 2015). Emerging evidence has 
suggested novel roles of Cx43-based HCs in cardiac homeostasis, as unopposed HCs reside 
in the periphery of GJ plaques termed perinexus (Rhett and Gourdie, 2012). In contrast to 
GJIC, Cx43-based HCs between the cytosol and the extracellular area of cardiomyocytes 
may, when open, lead to swelling, cell dysfunction and cell death (Plotkin et al., 2002, 
Goodenough and Paul, 2003, Wang et al., 2013c). Cx43 mRNA levels are found to be 
dramatically and rapidly downregulated in rat heart after injection of LPS. Of note, TNF-α 
decreases Cx43 gene promoter activity in H9c2 myoblast cells (Fernandez-Cobo et al., 
1999). Expression of transforming growth factor (TGF)-β, driving cell growth, cell 
differentiation, apoptosis and cellular homeostasis, is increased during T. cruzi infection and 
regulates fibrosis and the parasite cell cycle. Exposure to TGF-β induces disorganized GJ 
formation in non-infected cardiomyocytes, accompanied by punctate, diffuse and non-
uniform Cx43 staining (Waghabi et al., 2009). Analogous experiments have been performed 
with infected patients and confirmed downregulation of Cx43 expression, altered 
distribution of cardiac GJ plaques and a significant reduction in the number and length of 
Cx43-positive GJ plaques inversely correlating with cardiomegaly and sepsis (Celes et al., 
2007, Adesse et al., 2008, Waghabi et al., 2009, Carvalho et al., 2012).
2.2.2 Roles of connexins and their channels in inflammation in heart—In a 
recent set of studies, lipoxin A4, a bioactive product derived from arachidonic acid and a 
resolver of inflammation, showed protection of several organs against ischemia/reperfusion 
insults (Ye et al., 2011, Scully et al., 2012). In ischemia/reperfusion injury in rat, lowered 
levels of inflammatory cytokines, including IL-1β, IL-6, IL-8 and TNF-α, oxidative stress as 
well as increased quantities of Cx43 are measured after treatment with lipoxin A4. 
Moreover, lipoxin A4 preconditioning and postconditioning in myocardial ischemia/
reperfusion injury can attenuate metabolic disturbance in myocardium through upregulation 
of sodium/potassium ATPase expression, an important mediator in the maintenance of 
cardiac homeostasis (Zhao et al., 2013). Gap19 has been demonstrated to specifically inhibit 
Cx43-based HCs without affecting its corresponding GJs in cardiomyocytes (Wang et al., 
2013c). Importantly, this peptide prevents metabolic inhibition-enhanced HC opening, 
protects cardiomyocytes against volume overload and cell death following ischemia/
reperfusion in vitro, and modestly decreases the infarct size after myocardial ischemia/
reperfusion in mouse (Wang et al., 2013c). Murine macrophages co-cultured with murine 
atrial myocyte-derived cells and subjected to mechanical stretch show macrophage migration 
and transient increases in extracellular ATP concentration. These effects are blocked by the 
GJ and HC-blocker carbenoxolone and the non-specific ATP signaling modifiers apyrase 
and pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (Oishi et al., 2012). This outcome 
can be reversed if cells are incubated with SB-431542, an inhibitor of TGF-β receptor type I.
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2.3 Blood vessels
2.3.1 Effects of inflammation on connexins and their channels in blood 
vessels—Cx37, Cx40, Cx43 and Cx45 are expressed in the vascular wall. Cx43, Cx37 and 
Cx40 are present in endothelial cells, of which their expression levels depend on the type of 
vessel and its position in the vascular tree (Meens et al., 2015). Cx43, Cx45, Cx37 and Cx40 
can be found in smooth muscle cells (Table 1) (Scheckenbach et al., 2011). Lymphatic 
endothelial cells express Cx37, Cx43 and Cx47 (Meens et al., 2014). In all vascular cells, Cx 
proteins and their channels play an important role in the coordination of vascular responses. 
They drive the dynamic modulation of vascular resistance and blood flow to match different 
tissue oxygen requirements (Schmidt et al., 2008, Johnstone et al., 2009). Moreover, they 
participate in the development of lymphatic valves (Kanady et al., 2011, Sabine et al., 2012). 
Consequently, Cx proteins have also been described to be involved in pathological 
conditions of blood vessels, such as atherosclerosis (Pfenniger et al., 2013). The latter is a 
progressive disease characterized by the accumulation of macrophages, lymphocytes, 
smooth muscle cells and lipids in the vascular wall, and is tightly associated with 
inflammation. Cx37 is expressed in macrophage foam cells and monocytes, which are 
important mediators in the progression of atherosclerosis. ATP release through Cx37-based 
HCs is linked to inhibition of leukocyte adhesion, suggesting that these channels may 
control initiation of atherosclerotic plaque development (Wong et al., 2006). Both Cx37 and 
Cx40 productions are decreased in the endothelium of atherosclerotic plaques (Kwak et al., 
2002, Yeh et al., 2003) and their expression is altered by oxidative stress, prothrombotic 
molecules and pro-inflammatory agents (Simon et al., 2004, Hou et al., 2008). This is 
supported by complete disappearance of Cx37 and Cx40 when human umbilical vein 
endothelial cells are stimulated with TNF-α (van Rijen et al., 1998). Furthermore, Cx43 
expression is upregulated in experimental coronary atherosclerosis, especially in 
macrophage foam cells (Blackburn et al., 1995, Polacek et al., 1997, Kwak et al., 2002). 
Moreover, LPS-injected rats show enhanced Cx40 expression in the aorta with simultaneous 
increased levels of inflammatory markers, like C-reactive protein, and oxidative stress 
markers, including malondialdehyde. Omega-3 fatty acids negatively affect the expression of 
Cx40 in aortic tissue and suppress C-reactive protein and malondialdehyde production 
(Frimmel et al., 2014). LPS activates c-jun terminal kinases 1 and 2, p38 and extracellular 
signal-regulated kinases 1 and 2, yet it also abrogates GJ coupling in endothelial cells 
isolated from wild-type, Cx37-/- and Cx43G60S mutant mice (Bolon et al., 2007). Although 
the effects of inflammation on Cx expression and function may differ according to the 
vascular bed involved, treatment strategies targeting Cxs may improve disease outcome.
2.3.2 Roles of connexins and their channels in inflammation in blood vessels
—Cx37 seems to protect against atherosclerosis since deletion of Cx37 accelerates 
atherogenesis in Cx37-/-/apolipoproteinE-/- mice. These animals show an increase in aortic 
lesions caused by enhanced monocyte and macrophage recruitment (Wong et al., 2006). 
Shear stress, an essential feature of atherogenesis (Kwak et al., 2014), applied to the same 
mouse model is found to increase the atherosclerotic plaque size in Cx37-/-/
apolipoproteinE-/- animals in comparison with apolipoproteinE-/- counterparts (Pfenniger et 
al., 2015). When Cx37-/- monocytes or macrophages are introduced in hypercholesterolemic 
Cx37+/+ mice, a higher amount of leukocytes is found in the atherosclerotic plaque, 
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suggesting a role of Cx37 in monocyte and macrophage function (Wong et al., 2006). 
Conversely, a polymorphism of Cx37 or blockage of Cx37-based HCs reduces the release of 
ATP out of the cells and increases their adhesion to substrates (Chanson and Kwak, 2007). 
Endothelial-specific Cx40-/- mice show spontaneous atherosclerotic lesions in the aorta by 
promoting leukocyte adhesion through cluster of differentiation 73 (Chadjichristos et al., 
2010). The latter fulfills enzymatic activities through the conversion of ATP to adenosine 
monophosphate and adenosine in immune cells (Chadjichristos et al., 2010, Antonioli et al., 
2013). In contrast to the seemingly protective effects of Cx37 and Cx40, Cx43 rather acts in 
an atherogenic way. Indeed, low density lipoprotein receptor-/-/Cx43+/- mice fed a 
cholesterol-rich diet display reduced atherosclerosis in the thoraco-abdominal aorta and in 
the aortic roots in comparison with low density lipoprotein receptor-deficient mice. 
Specifically, smaller atherosclerotic plaques, fewer inflammatory cells and thicker fibrous 
caps are found (Kwak et al., 2003, Wong et al., 2003). Targeting the Cx43 microtubule-
binding domain by JM2, a Cx43 mimetic peptide identical to a sequence of the C-terminal 
intracellular loop, results in a decrease in ATP release in cultured human endothelial cells 
and decreases the total inflammatory infiltrate in a rat model of inflammation (Calder et al., 
2015), illustrating that targeting endothelial Cx43 might be a promising anti-inflammatory 
approach.
2.4 Liver
2.4.1 Effects of inflammation on connexins and their channels in liver—In 
liver, Cx32 and Cx26 are expressed by hepatocytes (Kyoi et al., 1992, Ohkusa et al., 1995, 
Iwata et al., 1998, Radebold et al., 2001). Non-parenchymal livers cells, including Kupffer 
cells, sinusoidal endothelial cells and stellate cells, produce Cx26 and Cx43 (González et al., 
2002, Eugenín et al., 2007, Hernández-Guerra et al., 2014). GJIC underlies critical hepatic 
functions, including xenobiotic biotransformation and plasma protein synthesis (Maes et al., 
2015b).
Upon injection of LPS in rodents, decreased Cx32 and Cx26 protein levels at the plasma 
membrane of hepatocytes are observed. This is reminiscent of what is observed in hepatitis 
patients in clinical settings (Correa et al., 2004). Additionally, Cx32 mRNA levels are 
diminished during the inflammatory response in liver, while Cx26 mRNA remains 
unchanged (De Maio et al., 2000). In primary hepatocyte cultures, IL-1β decreases Cx32 
levels and GJIC becomes compromised by TNF-α, IL-1β and IL-6. Hepatic Cx26 mRNA is 
upregulated after exposure of cultured immortalized hepatocytes to IL-1, IL-6 and TNF-α 
(Temme et al., 1998). The same holds true for Cx43 protein and mRNA in primary stellate 
cells exposed to LPS or IL-1β (Fischer et al., 2005). When treated with LPS and IFN-γ, 
Kupffer cells increasingly express Cx43 in vitro and in vivo (Eugenín et al., 2007). 
Moreover, GJIC deteriorates in mice upon intoxication with acetaminophen, which triggers 
an inflammatory response, and is associated with a switch in mRNA and protein production 
from Cx32 and Cx26 to Cx43. The upregulation of Cx43 expression is due, at least in part, 
to de novo production by hepatocytes (Maes et al., 2016a). Likewise, Cx32 production is 
drastically downregulated upon acute-on-chronic liver failure in rats. At the same time, 
Cx43-positive spots appear in particular in the vicinity of inflamed areas (Balasubramaniyan 
et al., 2013).
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2.4.2 Roles of connexins and their channels in inflammation in liver—Cx32 
exerts a protective effect in experimental non-alcoholic steatohepatitis, a chronic liver 
disease associated with fat accumulation and inflammation (Willebrords et al., 2015), as 
based upon increased levels of inflammatory cytokines and more pronounced oxidative 
stress in Cx32 dominant negative transgenic (Cx32ΔTg) rats (Sagawa et al., 2015). The role 
of Cx32 in liver injury is further investigated in Cx32-/- mice and Cx32ΔTg rats treated with 
acetaminophen. Both amplification and alleviation of this toxicological process by Cx32 is 
described (Naiki-Ito et al., 2010, Igarashi et al., 2014, Maes et al., 2016b). Acetaminophen 
causes liver damage, inflammation and oxidative stress upon overdose. However, Cx32-/- 
mice display no differences in inflammation, cell death and oxidative stress in comparison 
with wild-type mice (Maes et al., 2016b). Cx43+/- mice tend to show increased liver cell 
death, inflammation and oxidative stress, suggesting that hepatic Cx43-based signaling may 
protect against acetaminophen-induced liver toxicity (Maes et al., 2016a). In rat liver lobules 
treated with thioacetamide, disappearance of Cx32 at the cell borders of hepatocytes is 
observed. In primary cultures of rat hepatocytes, IL-1β causes the loss of Cx32. These 
effects are mitigated by a mitogen-activated protein kinase and p38 mitogen-activated 
protein inhibitor, respectively. This demonstrates the involvement of these signal 
transduction pathways in the regulation of Cx32 during the acute-phase response to IL-1β 
(Yamamoto et al., 2004).
2.5 Stomach and intestine
At least 10 different Cx types are expressed in the intestinal tract. Cx26, Cx32, Cx36, Cx37, 
Cx40, Cx43, Cx45 and Cx57 are detected in the small intestine of several species, whereas 
Cx26, Cx31, Cx31.1, Cx32, Cx36, Cx40, Cx43 and Cx45 are present in the colon (Table 1) 
(Maes et al., 2015a). The stomach produces 3 Cx species with Cx26 in epithelial cells and 
lamina propria of the fundus (Fiertak et al., 1999, Radebold et al., 2001, Liu et al., 2010), 
Cx32 in the glandular regions, specifically in foveolar cells (Kyoi et al., 1992, Uchida et al., 
1995, Radebold et al., 2001) and Cx43 in circular muscle layers in gastric tissue (Seki and 
Komuro, 2002, Nishitani et al., 2005). These Cx proteins have been linked with an array of 
gastrointestinal features including motility, gastric acid secretion and intestinal innate 
immune defense (Maes et al., 2015a).
Helicobacter pylori colonizes the gastric mucosa and harms the stomach by several 
mechanisms, such as produced ammonia, proteases, vacuolating cytotoxin A, 
phospholipases and cytotoxin associated gene (Cag) A (Smoot, 1997). Indeed, CagA-
positive Helicobacter pylori can cause gastritis, an inflammatory reaction of the stomach 
lining, and thereby abolish GJIC in cultured human gastric epithelial cells (Tao et al., 2007, 
Xu et al., 2011), while Cx43 expression is diminished in cultured human gastric carcinoma 
cells (Xu et al., 2007). Likewise, in gastric lesions of Helicobacter pylori-infected patients, 
Cx32 and Cx43 levels are reduced, especially with the CagA-positive variant (Jia et al., 
2008, Xu et al., 2008a, Xu et al., 2008b). Shigella flexneri, a species of Gram-negative 
bacteria, causes inflammation by invading the colonic mucosa. This induces the opening of 
Cx26-based HCs through actin and phospholipase C, which allows extracellular release of 
ATP (Tran Van Nhieu et al., 2003, Simpson et al., 2013). ATP is also found to be an early 
alert response to infection with enteric pathogens that eventually promote inflammation of 
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the gut. In colonic epithelium in mouse models of intestinal inflammation, Cx43 expression 
is lost completely (Sedhom et al., 2013). Similarly, Cx43 levels are decreased in enterocytes 
in a mouse model of necrotizing enterocolitis. In this case, the release of IFN-γ suppresses 
GJIC by inducing the dephosphorylation and internalization of Cx43 (Leaphart et al., 2007).
2.6 Skin
Skin, the largest organ of the body that forms a highly complex and organized protective 
barrier against the external environment, is constituted of 3 major layers, namely the 
epidermis, the dermis and the hypodermis. As the blood supply of the skin is limited to the 2 
latter layers, cell-to-cell communication is necessary to provide signals and nutrients to the 
outer skin layers. In skin, a plethora of Cx proteins is expressed, including Cx26, Cx30, 
Cx30.3, Cx31, Cx31.1, Cx32, Cx37, Cx40, Cx43 and Cx45. Keratinocytes mainly produce 
Cx26 and Cx43 (Richard, 2000), while human dermal fibroblasts contain Cx43 and Cx45 
and low quantities of Cx40 (Table 1) (Levit and White, 2015). These Cx species influence 
the coordination of cell proliferation, migration and differentiation events, thus maintaining 
epidermal homeostasis (Martin and van Steensel, 2015).
Mutations that cause inflammatory skin disease show dysregulated HCs composed of Cx26, 
Cx30, Cx31, and Cx43, as evidenced by extracellular ATP leakage and excessive cytosolic 
influx of calcium (Levit and White, 2015). Cx26 mutations, producing leaky HCs and 
disturbing GJ formation, can cause a diversity of skin diseases of which keratitis-ichthyosis-
deafness is accompanied by inflammation (Scott et al., 2012, Martin and van Steensel, 
2015). During wound healing in rat and human, a process that involves inflammation, Cx26 
and Cx30 levels are upregulated (Coutinho et al., 2003, Brandner et al., 2004, Sutcliffe et al., 
2015). In addition, hyperproliferation occurs and wound healing is suppressed by persistent 
expression of Cx26 in mouse epidermis. Mechanistically, ectopic expression of Cx26 in 
keratinocytes results in increased ATP release, which delays epidermal barrier recovery and 
promotes an inflammatory response in resident immune cells (Djalilian et al., 2006). In 
contrast, Cx43 production is lost at wound sites and surrounding areas of the epidermis in rat 
(Goliger and Paul, 1995), mouse (Coutinho et al., 2003) and human (Neub et al., 2007), but 
continues to be expressed in diabetic wounds (Wang et al., 2007). Bacterial cell wall 
components differentially influence expression levels and opening of Cx26-based (Donnelly 
et al., 2012) and Cx43-based HCs (Robertson et al., 2010). In this respect, peptidoglycan 
isolated from S. aureus promotes open HCs states in a human keratinocyte cell line 
transfected with keratitis-ichthyosis-deafness-associated Cx26 constructs. Furthermore, 
peptidoglycan stimulates ATP release into the extracellular milieu and increases IL-6 levels 
in human cervical cancer HeLa cells and human keratinocyte HaCaT cells expressing 
keratitis-ichthyosis-deafness mutants (Donnelly et al., 2012). Gap27 accelerates wound 
healing and elevates cell proliferation in ex vivo models of wound healing (Evans and 
Leybaert, 2007, Wright et al., 2009, Pollok et al., 2011). Additionally, targeting Cx43 with 
ACT1, a peptide mimetic of the carboxyl-terminus of Cx43, accelerates fibroblast migration 
and proliferation, and wound reepithelialization in adults with chronic venous leg ulcers 
(Ghatnekar et al., 2015). Similar promising results were obtained with antisense 
oligonucleotides targeting Cx43, improve wound closure events (Martin, 2015). When 
αCT1, a peptide based on the carboxyl-terminus of Cx43 is applied in the skin, a decreased 
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inflammatory response, reduced area of scar progenitor tissue, and restoration of more 
normal dermal structure and mechanical strength is found (Ongstad et al., 2013). 
Furthermore, it has been found that Cx43+/- mice show accelerated re-epithelialization and 
wound closure, increases proliferation and activation of dermal fibroblasts, and enhances the 
expression of extracellular matrix remodeling mediators (Cogliati et al., 2015).
2.7 Kidney
In kidney, Cx26, Cx30.3, Cx31, Cx32, Cx37, Cx40, Cx43, Cx45 and Cx46 are expressed, of 
which Cx37, Cx40, Cx43 and Cx45 are present in renal vasculature (Hanner et al., 2010, 
Abed et al., 2014a). Cx43 is found in vascular endothelium, smooth muscle of larger vessels, 
glomerular epithelial cells, proximal tubular cells and glomerular endothelial cells (Table 1) 
(Hillis et al., 1997b). GJs are involved in several physiological and pathological processes in 
kidney (Wagner and Kurtz, 2013). Indeed, maintaining normal renal hemodynamics requires 
regulation of renal vascular conductance, endothelium-derived vasodilatation and 
autoregulatory mechanisms, all which are controlled by Cx-based signaling (Wagner et al., 
2007, Wagner et al., 2010).
There is growing evidence of an intimate relation between Cx expression and the occurrence 
of inflammation in the kidney (Scheckenbach et al., 2011, Abed et al., 2014a). Cx37 and 
Cx40 are hereby considered anti-inflammatory renal Cx members, while Cx43 acts in a pro-
inflammatory way (Abed et al., 2014a, Abed et al., 2014b). Cx43 is strongly expressed by 
inflammatory cells, damaged tubular cells and interstitial cells and in the endothelium of 
peritubular and glomerular capillaries at the early stages of hypertensive nephropathy in 
mouse (Toubas et al., 2011). This pattern of Cx43 expression is very similar to that of 
intercellular adhesion molecule 1 and, to a lesser extent, of vascular cell adhesion molecule 
1, both produced by renal endothelium in inflammatory conditions. Cx43 is therefore 
thought to be primarily implicated in tubule-interstitial inflammation (Hillis et al., 1997a). 
Treatment of normal rat kidney epithelial cells with LPS results both in downregulation 
(Gerl et al., 2014) and upregulation (Fernandez-Cobo et al., 1998) of Cx43 expression. In 
contrast, Cx37, which is abundantly produced in the renal cortex of healthy mice, is 
markedly decreased in experimental models of chronic kidney disease (Toubas et al., 2011). 
In a Cx43+/- mouse model of chronic kidney disease, the renal cortex shows a decrease of 
cell adhesion markers leading to reduced monocyte infiltration and interstitial renal fibrosis. 
Interestingly, treatment with Cx43 antisense oligonucleotides improves renal function in 
mice suffering from chronic kidney disease. Furthermore, Cx43-specific blockage, by the 
Gap26 mimetic peptide, inhibits monocyte adhesion in activated endothelium and profibrotic 
pathways in tubular cells (Abed et al., 2014b).
2.8 Lung
Normal alveolar epithelium in vivo shows expression of Cx26, Cx32, Cx43 and Cx46 (Table 
1) (Koval, 2002). Nevertheless, different Cx species, like Cx30 and Cx31, can be found in 
airway cell lines and airway cells in primary culture in non-differentiated and differentiated 
circumstances (Wiszniewski et al., 2007). The continuous exposure to inhaled hostile factors 
makes lungs vulnerable to infection and inflammation. Therefore, proper tissue repair is of 
Willebrords et al. Page 12
Crit Rev Biochem Mol Biol. Author manuscript; available in PMC 2017 September 05.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
utmost importance for maintaining lung homeostasis and relies on Cx-based signaling (Losa 
and Chanson, 2015).
Impairment of physiological Cx expression in lung is associated with an abnormal immune 
response in cystic fibrosis, a genetic disease in which lungs become clogged due to mucus 
secretion (Chanson et al., 2001, Huang et al., 2003a, Huang et al., 2003b). In bronchiolar 
epithelial cells, loss of Cx37 expression is linked to allergic airway disease and cytokine 
production by T-helper cells (Park et al., 2007). Cx43 is thought to be of importance for 
calcium signaling in lung tissue in inflammatory conditions, such as during acute lung injury 
and acute respiratory distress syndrome (MacCallum and Evans, 2005). Work with 
endothelial Cx43-/- mice demonstrates that Cx43 mediates calcium wave propagation that 
acts to amplify the inflammatory process (Parthasarathi et al., 2006). Calcium waves are 
known to underlie leukocyte rolling in the vascular surface and blocking of Cx43-based 
channels by peptides results in reduction of neutrophil adhesion to the endothelial cell 
surface in a mouse pneumocyte cell line (Parthasarathi et al., 2006, Sarieddine et al., 2009). 
This pro-inflammatory role of Cx43 has been confirmed in vascular endothelium-specific 
Cx43-/- mice, exhibiting a decrease in neutrophil recruitment after LPS-induced lung 
inflammation (Sarieddine et al., 2009). In cultured human pulmonary endothelial cells 
treated with LPS, mRNA and protein levels of Cx43 as well as GJIC are increased. The 
decrease of transendothelial resistance triggered by LPS hereby is attenuated following 
small interfering RNA-mediated suppression of Cx43 production (O'Donnell et al., 2014). 
Cx40 expression is diminished in lung of mouse and rabbit suffering from acute lung injury 
induced by intranasal instillation of LPS. However, no differences in pulmonary 
inflammation are noticed in Cx40+/- mice in comparison with wild-type animals (Rignault et 
al., 2007). In a endothelial cell-specific Cx40-/- mouse model, downregulated production of 
cluster of differentiation 73 is observed (Chadjichristos et al., 2010). The latter seems to play 
a protective role in acute lung injury by preventing leukocyte adhesion to the endothelium 
(Thompson et al., 2004, Volmer et al., 2006).
2.9 Eye
Cx family members identified in the eye include Cx26, Cx30, Cx30.2, Cx32, Cx36, Cx37, 
Cx43, Cx45, Cx46, Cx50 and Cx57 (Table 1). Cx43 is expressed in multiple cell types of the 
eyes, including astrocytes, Müller cells, microglia, retinal pigment epithelium and 
endothelial cells and supports many aspects of eye development and normal physiology, but 
is equally involved in corneal inflammation (Danesh-Meyer et al., 2015).
Cultured human corneal fibroblasts exposed to TNF-α show reduced Cx43 expression. 
These effects are attenuated by an inhibitor of c-jun terminal kinase, suggesting the 
involvement of both the mitogen-activated protein kinase signaling pathway and Cx43 
production in corneal inflammation (Kimura et al., 2013). Incubation of retinal pigment 
epithelial cells with glucose induces accumulation of IL-6, IL-8 and TGF-β, and negatively 
affects Cx43 levels and GJIC (Losso et al., 2010).
Intense light exposure in albino rats increases Cx36 levels in the inner plexiform layer and 
lowers Cx45 quantities in the light-damaged retina, while Cx43 production becomes 
intensified in the retinal pigment epithelium and the choroid. In the latter, Cx43 colocalizes 
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with indicators of nitration-related oxidative stress, like nitrotyrosine, inflammatory markers, 
such as cluster of differentiation 45, and ionized calcium-binding adaptor molecule-1 (Guo 
et al., 2014). A number of studies show that reducing Cx43 expression, or blocking channel 
function, in the eye can be beneficial. Treatment of corneal scrape wounds or laser ablations, 
mimicking photorefractive keratectomy, with Cx43 antisense oligonucleotides increases the 
rate of epithelial recovery, whilst significantly reducing oedema, myofibroblast 
differentiation and proliferation (Grupcheva et al., 2012). This outcome has been confirmed 
using α-carboxy terminus 1, a Cx43 mimetic peptide, that also reduces healing time and 
inflammation in a rat model of corneal inflammation (Moore et al., 2013). The Cx43 
antisense oligonucleotides applied to humans with non-healing burns to the cornea under 
compassionate use promoted healing primarily by reducing inflammation and triggering 
vascular recovery to the limbus (Ormonde et al., 2012). Interestingly, injection of Cx43 
antisense oligonucleotides in a rabbit model of glaucoma results in less myofibroblast 
production and reduced scarring (Deva et al., 2012). When used in patients with repeated 
trabeculectomy block owing to scarring, the Cx43 antisense oligonucleotides reduces 
scarring and resulted in long term maintenance of normal intraocular pressure (Becker et al., 
2016). In a rat retina ischemia/reperfusion model, delivery of Peptide5, either systemically 
(Danesh-Meyer et al., 2012) or by intravitreal injection, considerably reduces vessel leak, 
significantly counteracts inflammation and promotes neuronal survival (Chen et al., 2013, 
Chen et al., 2015). Although Cx43 levels may be reduced in the diabetic retinal vessel bed 
(Tien et al., 2014, Tien et al., 2015), animal models and direct analysis of human donor 
tissues reveals very high levels of Cx43 associated with vessel endothelium, astrocytes and 
Müller cells near diabetic retinopathy lesions.
2.10 Immune cells
The immune system provides a variety of defenses against PAMPs and DAMPs. This occurs 
through the establishment of physical and chemical barriers and the concerted actions of a 
wide spectrum of biochemical mediators and immune cells (Glass et al., 2015). The 
expression and functional significance of several Cx family members, including Cx30.3, 
Cx32, Cx37, Cx40 and Cx43 (Table 1), have been documented in cells and tissues of the 
immune and lymphatic system (Oviedo-Orta and Howard Evans, 2004, Neijssen et al., 
2007). Cx43 is by far the most important Cx species in the immune system, being found in 
macrophages, neutrophils, dendritic cells, B-cells and T-cells (Glass et al., 2015). Cx43 
fulfills different functions, such as recruitment of neutrophils and T-cell activation (Glass et 
al., 2015). Circulating monocytes contain Cx43 and its expression is increased upon LPS 
treatment. The latter, together with IFN-γ, seems a prerequisite for establishing GJIC 
between cultured monocytes (Eugenín et al., 2003). This suggests that Cx43 may be of 
importance in the formation of GJIC in macrophages (Alves et al., 1996). Human tonsillar 
B-lymphocytes also express Cx43, which is upregulated in vitro after exposure to LPS 
(Oviedo-Orta et al., 2000).
In the presence of GJ and HC inhibitors, such as 18β-glycyrrhetinic acid or Cx mimetic 
peptides, cultured human lymphocytes produce less immunoglobulins M, G and A in 
response to phytohaemagglutinin activation. This indicates that inhibition of Cx43-based 
channels may result in disrupted communication between T-cells and B-cells or in 
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abrogation of immunoglobulin production (Oviedo-Orta et al., 2001). Moreover, dye 
coupling is present between dendritic cells, suggesting that Cx43 is capable of forming 
functional GJs between these cells. Decreased dendritic cells activation and antigen 
presentation are observed when cells are treated with Gap27 following exposure to IFN-γ 
and LPS (Matsue et al., 2006). Using different Cx blocking agents, it has been found that 
polymorphonuclear leukocytes release ATP through Cx43-based HCs in a protein/
phosphatase-A-dependent manner. This is confirmed in polymorphonuclear leukocytes 
derived from Cx43fl/fl mice, whereby activated polymorphonuclear leukocytes display 
decreased extracellular ATP liberation (Eltzschig et al., 2006). The release of ATP possibly 
plays a role in perpetuation of the inflammasome cycle in chronic disease conditions (Kim et 
al., 2016).
2.11 Other organs
Electrical and metabolic coupling between pancreatic β-cells is required for proper insulin 
secretion and effective glycemic control. In particular, β-cell-specific GJIC relies on Cx36-
based GJs, which ensure orchestrated insulin release across islets (Cigliola et al., 2013). 
Other Cx proteins identified in pancreas are Cx43, Cx45 and Cx32 (Charollais et al., 1999) 
(Table 1). Cx32-/- mice exhibit a deleterious course of acute pancreatitis with increased 
necrosis, oedema and inflammation of the exocrine pancreas (Frossard et al., 2003). In 
cerulein-induced pancreatitis, irsogladine, an enhancer of GJIC, lowers the severity of the 
disease, decreases serum and pancreatic amylase. This coincides with disappearance of 
Cx32 in the pancreatic acini (Ito et al., 1997). This is not the case in a similar model in rat, 
where Cx32 mRNA and protein levels are both increased upon induction of pancreatitis with 
cerulein (Ogoshi et al., 2002).
Myoblasts express several Cx proteins, of which Cx39, Cx40, Cx43 and Cx45 are present in 
developing myoblasts and injured adult skeletal muscle (Table 1) (Merrifield and Laird, 
2015). Cx43 has been detected in prefusional C2C12 myoblasts (Constantin and Cronier, 
2000) and in primary cultures, and drives the differentiation and regeneration of the skeletal 
muscle (Araya et al., 2005). Transient expression of Cx40 has been described in axial 
skeletal muscles of mouse embryos during myoblast fusion (Dahl et al., 1995). Other Cx 
species found in muscle include Cx39 and Cx45 (von Maltzahn et al., 2004, von Maltzahn et 
al., 2011). Denervation of fast skeletal muscle cells activates NF-κB and elevates mRNA 
levels of TNF-α and IL-1β, which clearly shows the onset of inflammation after 
denervation. These effects cannot be reproduced in Cx43fl/flCx45fl/fl mice. Interestingly, 
denervated myofibers display de novo formation of HCs composed of Cx39, Cx43, and 
Cx45 as well as increased expression of purinergic P2X7 receptors (Cea et al., 2013). 
Furthermore, when exposing cultured microvascular endothelial cells from murine skeletal 
muscle to LPS and hypoxia/reoxygenation, protein kinase A-specific phosphorylation of 
Cx40 is more reduced when compared to exposure to LPS or hypoxia/reoxygenation alone. 
This occurs through diminished electrical coupling between microvascular endothelial cells, 
which indicates phosphorylation-driven involvement of Cx40 in inflammation and ischemia/
reperfusion (Bolon et al., 2008).
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Cx43 is the most abundantly expressed Cx species in bone, including osteocytes, osteoblasts 
and osteoclasts (Civitelli et al., 1993, Donahue et al., 1995). In addition, Cx45 and Cx46 are 
present in osteoblastic cells (Chaible et al., 2011, Plotkin and Bellido, 2013) and Cx37 
production is found in osteoblasts, osteocytes and osteoclasts (Paic et al., 2009, Pacheco-
Costa et al., 2014), while chondrocytes are positive for Cx43, Cx45, Cx32 and Cx46 (Mayan 
et al., 2013). Expression of Cx43 (Su et al., 1997, Kato et al., 2013), Cx32 (Yamaoka et al., 
2000b), Cx40 and Cx45 (Yamaoka et al., 2002) has been demonstrated in cells of 
periodontal ligaments (Table 1). In cartilage in osteoarthritic shoulders, Cx43, collagen type 
I, and TNF-α levels are increased (Casagrande et al., 2015). This also holds true for 
fibroblast-like synoviocytes exposed to LPS. Treatment of collagen-induced arthritic rats 
with small interfering RNA directed against Cx43 ameliorates paw swelling and reduces the 
manifestation of arthritis (Tsuchida et al., 2013). These findings indicate that suppression of 
Cx43 production has an anti-inflammatory outcome in rat and efficiently counteracts 
arthritis. Increasing Cx43 expression enhances the production of IL-1 and IL-6, and 
increases the secretion of collagenases into conditioned cell culture medium of cultured 
synovial fibroblasts. Conversely, knockdown of Cx43 production by small interfering RNA 
decreases expression of many of these inflammatory genes (Gupta et al., 2014).
3 Conclusions
Inflammatory diseases, such as multiple sclerosis, atherosclerosis, arthritis, gastritis and 
non-alcoholic steatohepatitis, affect millions of people worldwide. In the last decade, Cx 
proteins and their channels have been extensively studied in inflammatory conditions in a 
broad spectrum of tissues and cells. Collectively, these efforts show that Cx proteins play an 
important role in inflammatory processes in various organs, including brain, heart, blood 
vessels, liver, intestines, skin, lung and eye (Kwak et al., 2002, Sarieddine et al., 2009, 
Scheckenbach et al., 2011, Martin et al., 2014, Glass et al., 2015, Maes et al., 2015b, Meens 
et al., 2015). A number of experimental tools, such as genetically altered animals 
(Parthasarathi et al., 2006, Wong et al., 2006, Markoullis et al., 2012a, Abed et al., 2014b, 
Sagawa et al., 2015), small interfering RNA duplexes (Tsuchida et al., 2013, Gupta et al., 
2014), HC blockers and GJ inhibitors (Matsue et al., 2006, Chanson and Kwak, 2007, 
O'Carroll et al., 2008, Deva et al., 2012, Wang et al., 2013c, Abed et al., 2014b), have 
allowed to gain a better insight into the molecular mechanisms underlying the involvement 
of Cx signaling in inflammation. Although to be considered with a lot of caution, genetic 
knockout experiments suggest that Cx43 seems to be a mainly pro-inflammatory Cx 
(Parthasarathi et al., 2006, Huang et al., 2012, Abed et al., 2014b), while Cx32 and Cx37 are 
rather anti-inflammatory (Table 3) (Frossard et al., 2003, Parthasarathi et al., 2006, Wong et 
al., 2006, Abed et al., 2014b, Sagawa et al., 2015). This is substantiated by studies that apply 
a variety of Cx-based channel blockers (Wright et al., 2009, Froger et al., 2010, Pollok et al., 
2011, Deva et al., 2012, Wang et al., 2013c, Chever et al., 2014). Nevertheless, most of the 
presently used Cx-based channel blockers inhibit GJs and HCs (Bodendiek and Raman, 
2010). Two potential exceptions include Gap19, which suppresses Cx43-based HC activity 
without affecting GJIC (Iyyathurai et al., 2013, Abudara et al., 2014), and Peptide5 
(O'Carroll et al., 2008). Peptide5 has been successfully delivered directly and systemically in 
a number of animal models, and owing to its extracellular acting mode of action, can be 
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targeted to disease and injury sites. Gap19 needs to cross the plasma membrane to be 
effective and is more difficult to target, but its asset is the very selective HC blocking 
capability without reducing GJIC. Since Cx43-based HCs are often associated with 
pathological conditions, Gap19 and Peptide5, or similar extracellular acting peptides (Evans, 
2015), could be of great value in the further investigation of the role of HCs in inflammation 
(Wang et al., 2013c, Abed et al., 2014b).
Overall, it can be concluded that Cxs and their channels play an important role in the 
inflammatory process and hence in a great number of highly prevalent diseases. This may 
provide opportunities for the search of novel drug targets and therapeutics for the clinical 
treatment of inflammatory diseases.
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ATP adenosine triphosphate
Cag cytotoxin associated gene
CL cytoplasmic loop
Cx connexin
DAMPs damage-associated molecular patterns
EL extracellular loop
FGF fibroblast growth factor
GJ(s) gap junction(s)
GJIC gap junctional intercellular communication
HC(s) hemichannel(s)
IFN interferon
IL interleukin
LPS lipopolysaccharide
NF nuclear factor
NO(S) nitric oxide (synthase)
PAMPs pathogen-associated molecular patterns
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TGF transforming growth factor
TM transmembrane domain
TNF tumor necrosis factor
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Figure 1. Structure of connexins and their channels.
GJs appear as plaques at the cell plasma membrane surface and are formed by the interaction 
of 2 HCs of adjacent cells. Each HC is composed of 6 Cx proteins, which are 
transmembrane proteins consisting of a cytoplasmic loop, 2 extracellular loops, a 
cytoplasmic C-terminal tail and a cytoplasmic N-terminal tail. (CL, cytoplasmic loop; EL, 
extracellular loop; TM, transmembrane domain).
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Figure 2. Role of connexin signaling in the initiation of inflammation.
PAMPs or DAMPs can interact with Toll-like receptors, which undergo dimerization upon 
activation. This triggers the migration of NF-κβ to the nucleus, where it activates gene 
transcription of pro-IL-1β. The latter is cleaved to mature IL-1β by caspase 1 in the cytosol, 
which influences the production of a number of pro-inflammatory mediators, such as TNF-
α, IL-6 and NOS. This characterizes the onset of the inflammatory reaction. GJs can transfer 
ATP between neighboring cells. HCs can release ATP into the extracellular environment 
after opening by pathogenic stimuli. ATP can then interact with P2X7 purinergic receptors at 
the cell plasma membrane and can influence the inflammatory process. (ATP, adenosine 
triphosphate; DAMPs, damage-associated molecular patterns; IL, interleukin; NF, nuclear 
factor; NOS, nitric oxide synthase; PAMPS, pathogen-associated molecular patterns; TNF, 
tumor necrosis factor).
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Table 1
Connexin expression in different organs.
(Cx, connexin).
Organ Cell type Cx species Reference
Brain Astrocytes Cx30, Cx43 (Dermietzel et al., 1991, Nagy and Rash, 2000)
Microglial cells Cx26, Cx32 (Eugenín et al., 2001, Parenti et al., 2002, Garg 
et al., 2005, Takeuchi et al., 2006, Kielian, 2008)
Oligodendrocytes Cx32, Cx47, Cx29 (Dermietzel et al., 1989, Altevogt et al., 2002, 
Odermatt et al., 2003)
Neurons Cx36, Cx45 (Takeuchi and Suzumura, 2014)
Blood-brain barrier endothelial 
cells
Cx37, Cx40, Cx43 (Little et al., 1995, Traub et al., 1998, Nagasawa 
et al., 2006, De Bock et al., 2014)
Blood-brain barrier pericytes Cx37, Cx40, Cx43 (Little et al., 1995, Traub et al., 1998, Nagasawa 
et al., 2006, De Bock et al., 2014)
Heart Smooth muscle cells Cx40, Cx43, Cx45 (Gros and Jongsma, 1996, Severs et al., 2004)
Cardiomyocytes Cx40, Cx43, Cx45 (Gros and Jongsma, 1996, Severs et al., 2004)
Blood vessels Endothelial cells Cx43, Cx37, Cx40 (Chadjichristos et al., 2010, Scheckenbach et al., 
2011)
Smooth muscle cells Cx43, Cx45, Cx40, Cx37 (Chadjichristos et al., 2010, Scheckenbach et al., 
2011)
Liver Sinusoidal endothelial cells Cx26, Cx43 (Hernández-Guerra et al., 2014)
Hepatic arteries and portal vein 
endothelial cells
Cx37, Cx40 (Fischer et al., 2005, Shiojiri et al., 2006)
Hepatocytes Cx26, Cx32 (Kyoi et al., 1992, Ohkusa et al., 1995, Iwata et 
al., 1998, Radebold et al., 2001)
Kupffer cells Cx26, Cx43 (González et al., 2002, Eugenín et al., 2007)
Stellate cells Cx26, Cx43 (Fischer et al., 2005, Maes et al., 2015b)
Stomach and intestines Stomach Cx26, Cx32, Cx40, Cx43, 
Cx45
(Wang and Daniel, 2001, Cousins et al., 2003, 
Liu et al., 2010, Wang et al., 2014)
Foveolar cell Cx32 (Fink et al., 2006)
Small intestine Cx26, Cx31, Cx57 (Filippov et al., 2003)
Musculus externa cell Cx40, Cx43 (Wang and Daniel, 2001, Liu et al., 2008)
Myenteric plexus cell Cx36, Cx40, Cx43, Cx45 (Wang and Daniel, 2001, Liu et al., 2008, 
Frinchi et al., 2013)
Epithelial cell Cx32, Cx37, Cx43 (Traoré et al., 2003, Husøy et al., 2004, Hakim 
et al., 2008)
Interstitial cell of cajal Cx43 (Seki and Komuro, 2002)
Colon Cx31, Cx31.9, Cx43 (Ismail et al., 2014, Li et al., 2015b)
Musculus externa cell Cx26, Cx40, Cx43 (Wang and Daniel, 2001, Mattii et al., 2013)
Myenteric plexus cell Cx36, Cx40, Cx43, Cx45 (Wang and Daniel, 2001, Frinchi et al., 2013, 
McClain et al., 2014)
Epithelial cell Cx26, Cx32, Cx37, Cx43 (Kanczuga-Koda et al., 2004, Kanady et al., 
2015)
Muscularis mucosa cell Cx43 (Ismail et al., 2014)
Interstitial cell of Cajal Cx43 (Nemeth et al., 2000)
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Organ Cell type Cx species Reference
Skin Keratinocytes Cx26, Cx30.3, Cx30, 
Cx31.1, Cx31, Cx40, 
Cx43, Cx45
(Di et al., 2001, Brandner et al., 2004, Wang et 
al., 2007, Churko and Laird, 2013, Martin et al., 
2014)
Fibroblasts Cx43, Cx45, Cx40 (Wright et al., 2009, Meyer et al., 2014, Cogliati 
et al., 2015, Tarzemany et al., 2015)
Melanocytes Cx43 (Haass et al., 2004, Rezze et al., 2011, Penuela 
et al., 2012)
Kidney Smooth muscle cells Cx37, Cx45 (Arensbak et al., 2001, Hanner et al., 2010, Li et 
al., 2015a)
Podocytes Cx43, Cx45 (Hanner et al., 2010, Morioka et al., 2013, Yang 
et al., 2014)
Pericytes Cx37 (Zhang et al., 2006, Hanner et al., 2010)
Mesangial cells Cx40, Cx45 (Arensbak et al., 2001, Kurtz et al., 2007, 
Hanner et al., 2010, Morioka et al., 2013)
Lung Alveolar epithelium Cx26, Cx32, Cx43, Cx46 (Koval, 2002)
Eye Lens epithelial cells Cx43, Cx50 (Berthoud et al., 2014)
Immune cells T-cells Cx40, Cx43 (Oviedo-Orta et al., 2000)
B-cells Cx40, Cx43 (Oviedo-Orta et al., 2000)
Monocytes Cx43 (Navab et al., 1991)
Macrophages Cx37, Cx43 (Beyer and Steinberg, 1991, Alves et al., 1996, 
Kwak et al., 2002)
Pancreas β-cells Cx36, Cx43, Cx45 (Charollais et al., 1999)
Exocrine pancreas Cx32 (Frossard et al., 2003)
Skeletal muscle Myoblasts Cx39, Cx40, Cx43, Cx45 (Merrifield and Laird, 2015)
Bone Osteocytes Cx37, Cx43 (Krüger et al., 2000, Paic et al., 2009, Pacheco-
Costa et al., 2014)
Osteoblasts Cx37, Cx43, Cx45, Cx46 (Civitelli et al., 1993, Donahue et al., 1995, 
Krüger et al., 2000, Chaible et al., 2011, Plotkin 
and Bellido, 2013)
Osteoclasts Cx37, Cx43 (Paic et al., 2009, Pacheco-Costa et al., 2014)
Chondrocytes Cx32, Cx43, Cx45, Cx46 (Mayan et al., 2013)
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Table 2
Effects of inflammation on connexins and their channels.
(Cx, connexin; FGF, fibroblast growth factor; GJIC, gap junctional intercellular communication; HC, 
hemichannel; IFN, interferon; IL, interleukin; LPS, lipopolysaccharide; mRNA, messenger ribonucleic acid; 
TGF, transforming growth factor; TNF, tumor necrosis factor).
Tissue Model Outcome Reference
Brain
Multiple sclerosis autoimmune encephalitis in 
mice
↓ Cx32-based and Cx47-based 
GJs in oligodendrocytes
↓ Cx43-based GJs in astrocytes
(Markoullis et al., 
2012a)
Multiple sclerosis patients ↓ Cx32-based and Cx47-based 
GJs in oligodendrocytes
↑ Cx30 and Cx43 protein in 
cortical lesions
(Lieury et al., 2014, 
Markoullis et al., 2014)
Rasmussen encephalitis patients ↓ Cx32 protein in cortex
= Cx26 protein in cortex
(Cepeda et al., 2015)
Intracerebroventricular injection of LPS in rats ↑ Cx32 mRNA in hippocampus
↑ Cx30 and Cx32 mRNA in 
hippocampus
↓ Cx43 protein in hippocampus
(Abbasian et al., 2013)
(Abbasian et al., 2012)
(Sayyah et al., 2012)
IL-1β-treated primary human fetal astrocytes ↓ GJIC
↓ Cx43 mRNA and protein
(John et al., 1999, 
Duffy et al., 2000)
TNF-α-treated primary rat astrocytes ↓ GJIC
Cx43 phosphorylation
(Haghikia et al., 2008b)
IL-1β and TNF-α-treated primary mouse 
astrocytes
↓ Cx43 protein and GJIC (Même et al., 2006)
LPS-treated primary rat astrocytes ↓ GJIC (Bolaños and Medina, 
1996)
TNF-α and IFN-γ-treated spinal rat astrocytes ↓ Cx43 mRNA, protein and GJIC (Zhang et al., 2013b, 
Zhang et al., 2015)
LPS-treated co-culture of rat primary astrocytes 
and rat primary microglia
↓ GJIC (Haghikia et al., 2008a, 
Hinkerohe et al., 2010)
LPS-treated co-culture of mouse primary 
astrocytes and mouse primary microglia
↓ GJIC
↑ HC activity
(De Vuyst et al., 2007, 
Fruscione et al., 2011)
(Retamal et al., 2007, 
Froger et al., 2009)
LPS-treated primary neonatal astrocytes ↓ Cx43 mRNA, protein and GJIC (Liao et al., 2010)
LPS-treated mouse microglia ↓ Cx32 mRNA, protein and GJIC (Takeuchi et al., 2006)
S. aureus-treated mouse brain slices ↑ HC activity
↓ GJIC
↑ Cx43 and Cx30 protein
(Karpuk et al., 2011)
Peptidoglycan-treated mouse primary microglia ↓ GJIC
↓ Cx43 and Cx30 mRNA and 
protein
↑ Cx26 mRNA and protein
(Garg et al., 2005)
Protozoan-treated rat astrocytes and 
leptomeningeal cells
↓ GJIC (Campos de Carvalho 
et al., 1998, Mele and 
Madrenas, 2010)
Human immunodeficiency virus-infected human 
astrocytes
↑ Cx43-based HC activity
↓ GJIC
(Orellana et al., 2014)
Mouse hepatitis virus-infected astrocytes and mice ↓ Cx43 protein
↓ GJIC
(Basu et al., 2015)
Peptidoglycan-treated immortalized mouse 
endothelial cells
↑ Cx43-based HC activity (Robertson et al., 2010)
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Tissue Model Outcome Reference
Spinal cord injury in rats ↑ Cx43 protein and mRNA in 
astrocytes
= Cx32 and Cx36 protein and 
mRNA
(Lee et al., 2005)
FGF-1-treated spinal astrocytes ↑ Cx43-based HC activity (Garré et al., 2010)
Heart
Injection of LPS in rats ↓ Cx43 mRNA (Fernandez-Cobo et al., 
1999)
TNF-α-treated rat myoblast cell line ↓ Cx43 promotor activity (Fernandez-Cobo et al., 
1999)
TGF-β-treated mouse embryotic cardiomyocytes ↓ GJIC (Waghabi et al., 2009)
T. cruzi-infected mouse embryotic cardiomyocytes ↓ GJIC (Waghabi et al., 2009)
T. cruzi-infected patients ↓ Cx43 protein (Waghabi et al., 2009)
T. cruzi-infected mouse cardiomyocytes ↑ Cx43 protein on short term
↓ Cx43 protein on long term
(Adesse et al., 2008)
Blood vessels
Hyperlipidemic mice ↓ Cx40 protein in endothelium
↓ Cx37 protein in endothelium
↑ Cx43 protein in endothelium
(Yeh et al., 2003)
Atherosclerotic mice ↓ Cx40 protein in endothelium
↓ Cx37 protein in endothelium
(Kwak et al., 2002)
Endothelium exposed to oxidative stress, 
prothrombotic molecules and cytokines
↓ Cx40 protein
↓ Cx37 protein
(Hou et al., 2008)
Coronary atherosclerosis patients ↑ Cx43 protein in coronary artery (Blackburn et al., 1995)
LPS-injected rats ↑ Cx40 protein in aorta (Frimmel et al., 2014)
TNF-α-treated human umbilical vein endothelial 
cells
↓ Cx37 mRNA
↓ Cx40 mRNA
(van Rijen et al., 1998)
LPS-injected mice ↓ Cx37 protein in aortic 
endothelium
↓ Cx40 protein in aortic 
endothelium
(Simon et al., 2004)
Liver
LPS-treated mice ↓ Cx32 and Cx26 protein
↓ Cx32 mRNA
↓ GJIC
(De Maio et al., 2000, 
Correa et al., 2004)
Hepatitis patients ↓ Cx32 protein (Yamaoka et al., 2000a, 
Nakashima et al., 2004)
IL-1β-treated primary hepatocytes ↓ Cx32 protein (Yamamoto et al., 
2004)
IL-1, IL-6 and TNF-α-treated immortalized 
hepatocytes
↑ Cx26 mRNA (Temme et al., 1998)
LPS-treated mice ↑ Cx26 mRNA (Temme et al., 2000)
LPS and IL-1β-treated primary stellate cell 
cultures
↑ Cx43 mRNA (Fischer et al., 2005)
LPS-treated primary Kupffer cell cultures ↑ Cx43 mRNA (González et al., 2002, 
Eugenín et al., 2007)
LPS and IFN-γ-treated primary Kupffer cell 
cultures
↑ Cx43 protein and mRNA (Eugenín et al., 2007)
Acetaminophen-treated mice ↑ Cx43 protein and mRNA in 
liver
↑ Cx43 protein in hepatocytes
↓ Cx32 and Cx26 protein and 
mRNA in liver
(Maes et al., 2016a)
Stomach and intestines
Atrophic gastritis in rats ↓ Cx32 protein (Nagahara et al., 1996, 
Miwa et al., 1997)
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Tissue Model Outcome Reference
Intestinal inflammation in mouse ↓ Cx43 protein in colonic 
epithelium
(Sedhom et al., 2013)
Necrotizing enterocolitits in mouse ↓ Cx43 protein in enterocytes
↓ GJIC
(Leaphart et al., 2007)
S. flexneri-infected human Cx26-transfected HeLa 
cells
↑ HC activity (Tran Van Nhieu et al., 
2003, Man et al., 2007)
S. flexneri-infected human mutated Cx26-
transfected HeLa cells
= HC activity (Man et al., 2007)
S. flexneri-infected human Cx30-transfected HeLa 
cells
= HC activity (Man et al., 2007)
S. flexneri-infected human Cx31-transfected HeLa 
cells
= HC activity (Man et al., 2007)
S. flexneri-infected human Caco-2/TC7 intestinal 
epithelial cells
↑ HC activity (Clair et al., 2008)
Yersinia enterocolitica-infected Cx43-transfected 
human cells
↑ HC activity
↑ Cx43 phosphorylation
(Wong and Isberg, 
2005)
Helicobacter pylory-infected human gastric 
epithelial cells
↓ GJIC (Yokoyama et al., 
2005)
Skin
Wound healing in rat ↑ Cx26 protein in epidermis
↑ Cx30 protein in epidermis
(Coutinho et al., 2003, 
Sutcliffe et al., 2015)
Wound healing in human ↑ Cx26 protein in skin slices
↑ Cx30 protein in skin slices
(Brandner et al., 2004, 
Sutcliffe et al., 2015)
Wounded epidermis of rat ↓ Cx43 protein (Goliger and Paul, 
1995)
Wounded epidermis of mice ↓ Cx43 protein (Coutinho et al., 2003)
Wounded epidermis of human ↓ Cx43 protein (Neub et al., 2007)
Diabetic wound in rat ↓ Cx43 protein in epidermis
↓ Cx26 protein in epidermis
↑ Cx43 protein in dermis
(Wang et al., 2007)
Peptidoglycan (S. epidermidis)-treated mouse 
endothelial cells
↑ GJIC
↑ HC activity
↑ Cx43 protein
(Robertson et al., 2010)
Peptidoglycan (S. epidermidis and S. aureus)-
treated keratinocytes
↑ Cx26-based HCs (Donnelly et al., 2012)
Peptidoglycan (S. epidermidis and S. aureus)-
treated HeLa cells
↑ Cx26-based HCs (Donnelly et al., 2012)
Kidney
LPS-treated rat kidney epithelial cells ↓ Cx43 (Gerl et al., 2014)
LPS-treated rat kidney epithelial cells ↑ Cx43 (Fernandez-Cobo et al., 
1998)
Glucose-treated human cortical collecting duct 
cells
↑ Cx43 protein and mRNA 
through TGF-β1
(Hills et al., 2009)
Chronic kidney-diseased mice ↓ Cx37 protein and mRNA (Toubas et al., 2011)
Chronic kidney-diseased patients ↑ Cx43 protein (Abed et al., 2014b)
TGF-β1 human collecting duct cells ↑ Cx43 protein
↑ GJIC
(Hills et al., 2009)
Tubulointerstitial inflammation in humans ↑ Cx43 protein (Hillis et al., 1997a)
Lung
Ovalbumin-induced allergic airway disease in mice ↓ Cx37 protein and mRNA (Park et al., 2007)
LPS-treated human pulmonary endothelial cells ↑ Cx43 protein
↑ GJIC
(O'Donnell et al., 2014, 
Kandasamy et al., 
2015)
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Tissue Model Outcome Reference
Acute lung injury in rabbit ↓ Cx40 protein (Rignault et al., 2007)
Eye
TNF-α-exposed human corneal fibroblasts ↓ Cx43 protein (Kimura et al., 2013)
Glucose-treated retinal pigment epithelial cells ↓ Cx43 protein
↓ GJIC
(Losso et al., 2010)
Intense light exposure in albino rats ↑ Cx36 protein in inner plexiform 
layer
↓ Cx45 protein in retina
↑ Cx43 protein in choroid
(Guo et al., 2014)
Diabetic retinal vessel ↓ Cx43 protein (Tien et al., 2014, Tien 
et al., 2015)
Immune cells
LPS-treated monocytes ↑ Cx43 protein and mRNA (Eugenín et al., 2003)
LPS-treated human tonsillar B-lymphocytes ↑ Cx43 protein and mRNA (Oviedo-Orta et al., 
2000)
Skeletal muscle Denervated myofibers De novo expression Cx39-based, 
Cx43-based and Cx45-based HCs
(Cea et al., 2013)
Bone
Osteoarthritic shoulders ↑ Cx43 protein in cartilage (Casagrande et al., 
2015)
LPS-treated fibroblast-like synoviocytes ↑ Cx43 mRNA (Tsuchida et al., 2013)
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Table 3
Roles of connexins and their channels in inflammation.
(ATP, adenosine triphosphate; Cx, connexin; HC, hemichannel; IFN, interferon; IL, interleukin; LPS, 
lipopolysaccharide; TNF, tumor necrosis factor).
Tissue Model Outcome Reference
Brain
Cx43 blocking in cytokine-treated astrocytes ↓ neurotoxicity (Froger et al., 2010)
Multiple sclerosis autoimmune encephalitits in Cx32-/- 
mice
↓ loss of Cx47 and Cx43-based 
GJs
(Markoullis et al., 
2012a)
Autoimmune encephalitic in astrocyte-specific 
Cx43fl/flCx30-/- mice
No alteration in susceptibility or 
severity of encephalitis
(Lutz et al., 2012)
Cx43 HC-blocking peptides-treated ischemic near-term 
sheep
↑ electroretinography outcome
↓ seizure
↓ status epilepticus
↑ oligodendrocyte and neuronal 
survival
(O'Carroll et al., 2008, 
Davidson et al., 2012)
Astrocyte-specific Cx43fl/fl mice ↓ ATP-induced inflammation↓ macrophage and microglial 
recruitment
↑ recovery following spinal cord 
injury
(Huang et al., 2012)
Connexin-blocking and Cx37/Cx43 knockdown in 
bradykinin-induced calcium oscillations in immortalized 
and primary brain endothelial cells
↓ calcium oscillations (De Bock et al., 2011)
Heart
LipoxinA4-treated ischemic rats ↓ IL-1β, IL-6, IL-8, TNF-α, and 
oxidative stress
↑ Cx43 expression
↑ Na+-K+-ATPase expression
(Zhao et al., 2013)
Gap19-treated ischemia/reperfusion in mice ↓ metabolic inhibition-enhanced 
HC opening
↓ volume overload
↓ cell death
(Wang et al., 2013c)
Co-culture of murine macrophages and murine atrial 
myocytes subjected to mechanical stretch, carbenoxolone 
and apyrase
↓ macrophage migration
↓ increase extracellular ATP
(Oishi et al., 2012)
Blood vessels
Atherosclerotic Cx37-/-apolipoproteinE-/- mice ↑ aortic lesions (Wong et al., 2006, 
Pfenniger et al., 2015)
Cx37-/- monocytes or macrophages introduced in 
hypercholesterolemic Cx37+/+ mice
↑ leukocytes in atherosclerotic 
plaque
(Chanson and Kwak, 
2007)
Polymorphism of Cx37 or blocking of Cx37-based HCs ↓ ATP release (Chanson and Kwak, 
2007)
Endothelial-specific Cx40-/- mice Spontaneous atherosclerotic 
lesions in aorta
(Chadjichristos et al., 
2010)
Atherosclerotic low density lipoprotein receptor-/-Cx43+/- 
mice
↓ aortic atherosclerosis
↓ atherosclerotic plaques
↓ leukocytes
(Kwak et al., 2003)
Liver
Non-alcoholic steatohepatitic Cx32ΔTg rats ↑ inflammation, oxidative stress (Sagawa et al., 2015)
Acetaminophen-treated Cx32-/- mice No effect on inflammation or 
oxidative stress
(Maes et al., 2016b)
Acetaminophen-treated Cx43+/- mice Tendency of higher cell death, 
inflammation and oxidative stress
(Maes et al., 2016a)
Skin
Cx43 blocking in wound healing models ↓ wound healing time, 
inflammation
(Qiu et al., 2003, Mori 
et al., 2006, Cogliati et 
al., 2015)
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Tissue Model Outcome Reference
Gap27-treated skin ↑ cell proliferation (Evans and Leybaert, 
2007, Wright et al., 
2009, Pollok et al., 
2011)
ACT1-treated chronic venous leg ulcers ↑ fibroblast migration and 
proliferation
↑ wound reepithelialization
(Ghatnekar et al., 2015)
αCT1-treated skin ↓ inflammatory response,
↓ area of scar progenitor tissue
restoration of dermal structure
(Ongstad et al., 2013)
Cx43+/- mice ↑ wound healing (Cogliati et al., 2015)
Kidney
Chronic kidney diseased Cx43+/-mice ↓ monocyte infiltration↓ fibrosis
(Abed et al., 2014b)
Cx43 antisense-treated chronic kidney diseased mice ↑ renal function (Abed et al., 2014b)
Cx43-specific blocking in chronic kidney diseased mice ↓ monocyte adhesion
↓ profibrotic pathways
(Abed et al., 2014b)
Lung
Endothelial-specific Cx43-/- mice ↓ calcium wave propagation (Parthasarathi et al., 
2006)
LPS-induced lung inflammation in endothelial-specific 
Cx43-/- mice
↓ neutrophil recruitment (Sarieddine et al., 2009)
LPS-treated endothelial-specific Cx40-/- in mice ↑ migration of neutrophils from 
blood to lungs
(Chadjichristos et al., 
2010)
Eye
Cx43 blocking in glaucoma trabeculectomy surgery in 
rabbit
↓ scarring
↓ Cx43 upregulation
(Deva et al., 2012)
αa-carboxy terminus 1-treated-rats of corneal 
inflammation
↓ healing time
↓ inflammation
(Moore et al., 2013)
Cx43 antisense oligonucleotides-treated cornel scrape 
wounds
↑ epithelial recovery
↓ oedema
↓ myofibroblast differentiation and 
proliferation
(Grupcheva et al., 2012)
α-carboxy terminus 1-treated corneal-wounded rats ↓ healing time
↓ inflammation
(Moore et al., 2013)
Cx43 antisense oligonucleotides-treated rabit model of 
glaucoma
↓ myofibroblast production
↓ scarring
(Deva et al., 2012)
Cx43 antisense oligonucleotides-treated trabeculectomy 
patients
↓ scarring
Long term maintenance of normal 
intraocular pressure
(Becker et al., 2016)
Peptide5-treated rat model of retina ischemia/reperfusion ↓ vessel leak
↓ inflammation
↑ neuronal survival
(Chen et al., 2013, 
Chen et al., 2015)
Immunecells
18β-glycyrrhetinic acid or Cx mimetic peptides-treated 
human lymphocytes
↓ immunoglobulins M, G and A (Oviedo-Orta et al., 
2001)
Gap27-treated dendritic cells exposed to IFN-γ and LPS ↓ activation
↓ antigen presentation
(Matsue et al., 2006)
Activated polymorphonuclear leukocytes from Cx43fl/fl ↓ extracellular ATP release (Eltzschig et al., 2006)
Pancreas Cx32-/- mice Acute pancreatitis (Frossard et al., 2003)
Skeletal muscle Cx43fl/flCx45fl/fl mice ↓ denervation (Cea et al., 2013)
Bone
Cx43 small interfering RNA-treated arthritic rats ↓ arthritis (Tsuchida et al., 2013)
Cx43 small interfering RNA-treated synovial fibroblasts ↓ expression inflammatory genes (Gupta et al., 2014)
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